Fingerprint
Dive into the research topics of 'Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19
Daniel Clark Files, Frank Tacke, Alexandra O’Sullivan, Patrick Dorr, William G. Ferguson, William G. Powderly
Research output: Contribution to journal › Review article › peer-review
22
Scopus
citations